Beam Therapeutics Normalized Basic EPS (Quarterly) Trends

Beam Therapeutics, Inc. (BEAM)

35.94 +8.39 (+30.45%) USD | NASDAQ | Jan 12, 11:18

View Normalized Basic EPS (Quarterly) for BEAM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Normalized Basic EPS (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Normalized Basic EPS (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Normalized Basic EPS (Quarterly) Benchmarks

Start Trial

Intellia Therapeutics, Inc.	Upgrade
Twist Bioscience Corp.	Upgrade
ANI Pharmaceuticals, Inc.	Upgrade
Pacific Biosciences of California, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade